DE2016112A1 - - Google Patents
Info
- Publication number
- DE2016112A1 DE2016112A1 DE19702016112 DE2016112A DE2016112A1 DE 2016112 A1 DE2016112 A1 DE 2016112A1 DE 19702016112 DE19702016112 DE 19702016112 DE 2016112 A DE2016112 A DE 2016112A DE 2016112 A1 DE2016112 A1 DE 2016112A1
- Authority
- DE
- Germany
- Prior art keywords
- aminopyrimidine
- compounds according
- salt
- amino
- alkylene chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 20
- -1 methylene, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, Undecylene, dodecylene, tridecylene, tetradecylene, Pentadecylene, hexadecylene Chemical group 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 claims description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 150000005005 aminopyrimidines Chemical class 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical class NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 3
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- 125000004442 acylamino group Chemical group 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000008018 melting Effects 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 2
- KSMRODHGGIIXDV-YFKPBYRVSA-N N-acetyl-L-glutamine Chemical compound CC(=O)N[C@H](C(O)=O)CCC(N)=O KSMRODHGGIIXDV-YFKPBYRVSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 2
- 229960003151 mercaptamine Drugs 0.000 description 2
- OWOHWGNSBBGHTI-YFKPBYRVSA-N n-[(3s)-2,6-dioxooxan-3-yl]acetamide Chemical compound CC(=O)N[C@H]1CCC(=O)OC1=O OWOHWGNSBBGHTI-YFKPBYRVSA-N 0.000 description 2
- BNJOQKFENDDGSC-UHFFFAOYSA-N octadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCC(O)=O BNJOQKFENDDGSC-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940014800 succinic anhydride Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XRAYFSUNOAHMAS-LURJTMIESA-N (2s)-2-(butanoylamino)pentanedioic acid Chemical compound CCCC(=O)N[C@H](C(O)=O)CCC(O)=O XRAYFSUNOAHMAS-LURJTMIESA-N 0.000 description 1
- GRFZRKRCZZCDNZ-QMMMGPOBSA-N (2s)-2-(pentylamino)pentanedioic acid Chemical compound CCCCCN[C@H](C(O)=O)CCC(O)=O GRFZRKRCZZCDNZ-QMMMGPOBSA-N 0.000 description 1
- DKKGGIHZVKOAPK-YFKPBYRVSA-N (2s)-2-(propanoylamino)pentanedioic acid Chemical compound CCC(=O)N[C@H](C(O)=O)CCC(O)=O DKKGGIHZVKOAPK-YFKPBYRVSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- YHVFECVVGNXFKO-UHFFFAOYSA-N 4-guanidinobutanamide Chemical compound NC(=O)CCCNC(N)=N YHVFECVVGNXFKO-UHFFFAOYSA-N 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- 240000005702 Galium aparine Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229910003202 NH4 Inorganic materials 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- UOQACRNTVQWTFF-UHFFFAOYSA-N decane-1,10-dithiol Chemical compound SCCCCCCCCCCS UOQACRNTVQWTFF-UHFFFAOYSA-N 0.000 description 1
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- YOURXVGYNVXQKT-UHFFFAOYSA-N oxacycloundecane-2,11-dione Chemical compound O=C1CCCCCCCCC(=O)O1 YOURXVGYNVXQKT-UHFFFAOYSA-N 0.000 description 1
- RMIBXGXWMDCYEK-UHFFFAOYSA-N oxonane-2,9-dione Chemical compound O=C1CCCCCCC(=O)O1 RMIBXGXWMDCYEK-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 1
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB17557/69A GB1259685A (en) | 1969-04-03 | 1969-04-03 | Amino-pyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2016112A1 true DE2016112A1 (enExample) | 1970-10-15 |
Family
ID=10097267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702016112 Pending DE2016112A1 (enExample) | 1969-04-03 | 1970-04-03 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3714165A (enExample) |
| AT (1) | AT296995B (enExample) |
| BE (1) | BE748133A (enExample) |
| CH (1) | CH515244A (enExample) |
| DE (1) | DE2016112A1 (enExample) |
| ES (1) | ES378042A1 (enExample) |
| FR (1) | FR2038201B1 (enExample) |
| GB (1) | GB1259685A (enExample) |
| NL (1) | NL7003911A (enExample) |
| OA (1) | OA03417A (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE38224T1 (de) * | 1983-09-01 | 1988-11-15 | Boehringer Ingelheim Ltd | Diazin-ethenylphenyloxamidsaeuren und deren ester und salze. |
| US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
| US5264435A (en) * | 1988-12-29 | 1993-11-23 | Mitsui Petrochemical Industries, Ltd. | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
-
1969
- 1969-04-03 GB GB17557/69A patent/GB1259685A/en not_active Expired
-
1970
- 1970-03-09 US US00017930A patent/US3714165A/en not_active Expired - Lifetime
- 1970-03-19 NL NL7003911A patent/NL7003911A/xx unknown
- 1970-03-24 FR FR7010454A patent/FR2038201B1/fr not_active Expired
- 1970-03-26 CH CH460870A patent/CH515244A/fr not_active IP Right Cessation
- 1970-03-27 BE BE748133D patent/BE748133A/xx unknown
- 1970-03-30 ES ES378042A patent/ES378042A1/es not_active Expired
- 1970-04-02 OA OA53891A patent/OA03417A/xx unknown
- 1970-04-03 DE DE19702016112 patent/DE2016112A1/de active Pending
- 1970-04-03 AT AT306470A patent/AT296995B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE748133A (fr) | 1970-08-31 |
| FR2038201B1 (enExample) | 1974-03-22 |
| ES378042A1 (es) | 1972-05-16 |
| AT296995B (de) | 1972-03-10 |
| FR2038201A1 (enExample) | 1971-01-08 |
| NL7003911A (enExample) | 1970-10-06 |
| CH515244A (fr) | 1971-11-15 |
| GB1259685A (en) | 1972-01-12 |
| OA03417A (fr) | 1970-12-15 |
| US3714165A (en) | 1973-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2230383B2 (de) | Phenoxyalkylcarbonsäurederivate und Verfahren zu deren Herstellung und deren Verwendung | |
| DE1793745A1 (de) | Arylsubstituierte biguanide | |
| DE2535930C3 (de) | Abietinsaureamidderivate und Verfahren zu ihrer Herstellung | |
| DE1154119B (de) | Verfahren zur Herstellung von 2-(2', 4', 6'-Trimethylbenzyl)-1, 3-diazacyclopenten-(2) und seinen Salzen | |
| AT209895B (de) | Verfahren zur Herstellung von 3-Amino-2,4,6-trijodbenzoylverbindungen | |
| EP0056970B1 (de) | Basisch substituierte Anthranilsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| CH369759A (de) | Verfahren zur Herstellung von N-Alkylpiperidin-a-carbonsäureaniliden | |
| DE3041812A1 (de) | Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel | |
| DE2623257A1 (de) | Verfahren zur herstellung von n-alkenyl-2-aminomethyl-pyrrolidinen | |
| DE1670143C3 (enExample) | ||
| DE1518400A1 (de) | Verfahren zur Herstellung von Aminoalkansulfonsaeuren | |
| CH644763A5 (de) | Szintigraphisches mittel und verfahren zu seiner herstellung. | |
| DE2059354C3 (de) | 3 '-Trif kiormethylbenz- (2-aminoalkyl) anilide, deren Säureadditionsalze und quartären Ammoniumsalze, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel | |
| DE929129C (de) | Verfahren zur Herstellung von Diphenylamiden | |
| AT276393B (de) | Verfahren zur Herstellung von neuen Dibenzocycloheptenderivaten, deren Ketalen und/oder Säureadditionssalzen | |
| AT205031B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Derivaten von 4-Aza-phenthiazinen bzw. ihren Salzen | |
| DE1150976B (de) | Verfahren zur Herstellung von als Psychotherapeutica geeigneten basischen Fluorenverbindungen | |
| DE1817861A1 (de) | N-alkylierte 3,4-Methylendioxymandelsaeureamidine und deren pharmakologisch nicht giftige Saeureanlagerungssalze und diese enthaltende pharmazeutische Mittel | |
| AT212313B (de) | Verfahren zur Herstellung von neuen, N-substituierten 2-Phenyl-7-amino-alkoxy-chromonen | |
| DE2327414A1 (de) | Verfahren zur herstellung von 2-alkoxy-4,5-substituierten benzamiden | |
| DE1768818C3 (de) | Anthranilsäureamide und Verfahren zu deren Herstellung | |
| DE1470121A1 (de) | Verfahren zur Herstellung von neuen pharmakologisch wirksamen Alkylendiamin-Derivaten | |
| CH467238A (de) | Verfahren zur Herstellung von 5H-Dibenzo-(a,d)-cycloheptenen | |
| DD226895A1 (de) | Verfahren zur herstellung von pyroglutamylhistidyltryptophan | |
| DE1695794B2 (de) | 4-acyl-3,4-dihydro-2(1h)-chinoxalinon-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SH | Request for examination between 03.10.1968 and 22.04.1971 |